Want to join the conversation?
Analyst Jimmy Baker of B. Riley & Company asks about $MPAA's FY17 revenue guidance and annualized run rate. CFO David Lee said the majority of revenue will be from existing product growth and the run rate is expected to be a percentage higher than the calendar year revenue. The vast majority of growth is expected to start mid-year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?